Patents by Inventor Naoya Kimoto

Naoya Kimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8642032
    Abstract: The present invention provides a method for screening a patient to be administered with a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient, said method comprising collecting samples from patients who expresses an antigen which is recognized by the anti-cancer antibody, measuring cadherin function in the samples, and selecting a patient whose the cadherin function is decreased or deleted; a method for screening a patient who has a high efficacy ratio for a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient; and a method for improving an efficacy ratio for a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: February 4, 2014
    Assignees: Kyowa Hakko Kirin Co., Ltd., Japan as Represented by President of National Cancer Center
    Inventors: Takashi Sato, Naoya Kimoto, Yuji Ohki, Akiko Furuya, Hiroyuki Ishida, Atsushi Ochiai
  • Patent number: 8192736
    Abstract: The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: June 5, 2012
    Assignee: Kyowa Hakko Kirin Co., Ltd
    Inventors: Etsuo Ohshima, Hirokazu Kawasaki, Naoya Kimoto, Akihiko Watanabe
  • Publication number: 20100189724
    Abstract: The present invention provides a method for screening a patient to be administered with a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient, said method comprising collecting samples from patients who expresses an antigen which is recognized by the anti-cancer antibody, measuring cadherin function in the samples, and selecting a patient whose the cadherin function is decreased or deleted; a method for screening a patient who has a high efficacy ratio for a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient; and a method for improving an efficacy ratio for a pharmaceutical composition which comprises an anti-cancer antibody as an active ingredient.
    Type: Application
    Filed: June 26, 2008
    Publication date: July 29, 2010
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Takashi Sato, Naoya Kimoto, Yuji Ohki, Akiko Furuya, Hiroyuki Ishida, Atsushi Ochian
  • Publication number: 20090252723
    Abstract: The present invention provides a therapeutic agent for endometriosis comprising an interleukin-5 antagonist as an active ingredient.
    Type: Application
    Filed: October 28, 2005
    Publication date: October 8, 2009
    Applicant: KYOWA HAKKO KOGYO CO., LTD>
    Inventors: Etsuo Ohshima, Hirokazu Kawasaki, Naoya Kimoto, Akihiko Watanabe